Chapter 3

ADME/Tox Predictions in Drug Design

Ricardo Pereira Rodrigues, Jonathan Resende de Almeida, Evandro Pizeta Semighini, Flávio Roberto Pinsetta, Susimaire Pedersoli Mantoani, Vinicius Barreto da Silva and Carlos Henrique Tomich de Paula da Silva

Abstract

Most drug candidate failures during clinical trials occur due to inappropriate ADMET properties. In this way, there is a major concern to identify possible ADMET failures during the early stages of drug design projects and optimize such properties in order to reduce time and costs. In silico ADMET predictions comprise various strategies that play a central role when considering the task of profiling lead compounds regarding potential ADMET failures. We will discuss the computational strategies, methods and softwares used, actually, to profile ADMET and how they could be helpful during drug design.

Total Pages: 192-212 (21)

Purchase Chapter  Book Details